Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department

a study on Myofascial Trigger Point Pain Myofacial Pain

Summary

Eligibility
for people ages 18 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Location
at Orange, California
Dates
study started
completion around
Principal Investigator
by Jonathan Lee, MD

Description

Summary

The aim of this trial is to investigate the efficacy of trigger point injections with 1% lidocaine in reducing myofascial back and neck pain in the Emergency Department compared to lidocaine patches 5%.

Official Title

A Randomized Controlled Study Comparing Trigger Point Injections With 1% Lidocaine Versus 5% Lidocaine Patch for Myofascial Pain in the Emergency Department

Details

After being informed about the study and the potential risks and benefits, all patients will be randomized into either the trigger point injection group with 1% lidocaine, or the 5% lidocaine patch group. Pain scores will be recorded while in the emergency department, and we will have a 5 day follow-up phone call to assess efficacy. Patients who present to UCI Department of Emergency medicine will be screened and recruited prospectively, and information regarding this study will be available on clinicaltrials.gov as a method of recruitment.

Keywords

Myofascial Trigger Point Pain, Myofacial Pain, pain management, emergency department, trigger point injections, lidocaine patches, myofascial pain, interventional pain medicine, Myofascial Pain Syndromes, Emergencies, Facial Pain, Lidocaine, Trigger point injection with 1% lidocaine, Lidocaine patch 5%

Eligibility

You can join if…

Open to people ages 18 years and up

  • 18 years or older
  • Diagnosed with myofascial pain of the posterior neck or back. *The diagnosis of myofascial pain was based on established criteria of having a palpable taut band (trigger point) that when depressed reproduced the patient's pain.

You CAN'T join if...

  • midline spinal tenderness
  • evidence of radiculopathy
  • pregnant
  • have an allergy to lidocaine
  • altered or deemed incapable of making informed consent
  • had signs of infection or skin breakdown over the trigger point.

Location

  • Emergency Room at UCI Medical Center accepting new patients
    Orange California 92868 United States

Lead Scientist at UC Irvine

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Irvine
ID
NCT05151510
Phase
Phase 4 research study
Study Type
Interventional
Participants
Expecting 110 study participants
Last Updated
Contact us about this trial